InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Friday, 09/04/2020 7:54:01 PM

Friday, September 04, 2020 7:54:01 PM

Post# of 403036
Take heart...

Brilacidin, being a defensin mimetic, is not a one trick pony. It could be described as a ‘genius pony’. It has outstanding initial data sets and safety profile. Those aren’t going away.

https://static1.squarespace.com/static/5715352e20c647639137f992/t/5e9cebd48660e44c2754fa00/1587342453349/Brilacidin+for+COVID-19+Overview+-+MOA%2C+PreClinical+Data%2C+Academic+Literature+-+4.20.20.pdf

Yeah...we’re all anxiously awaiting the RBL and FDA statements for further fact finding. It’s coming. And Brilacidin’s chance to bask in the spotlight is still possible.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News